Long‐Term Efficacy and Safety of Protease Inhibitor Switching to Nevirapine in HIV‐Infected Patients with Undetectable Virus Load

1 October 2004

journal article
clinical trial
Published by Oxford University Press (OUP) in Clinical Infectious Diseases

Vol. 39 (7) , 1024-1029
https://doi.org/10.1086/423385

Abstract

Background. Simplified highly active antiretroviral therapy (HAART) regimens are becoming widely used, particularly as a result of the side effects of and difficult compliance with protease inhibitor (PI) therapy. However, the long-term efficacy of HAART has not been properly assessed.

Keywords

This publication has 22 references indexed in Scilit:

Meta-analysis of randomized controlled trials of simplified versus continued protease inhibitor-based antiretroviral therapy in HIV-1-infected patients
AIDS, 2003
A Cohort Study of Nevirapine Tolerance in Clinical Practice: French Aquitaine Cohort, 1997–1999
Clinical Infectious Diseases, 2002
Virological, Immunological, and Clinical Impact of Switching from Protease Inhibitors to Nevirapine or to Efavirenz in Patients with Human Immunodeficiency Virus Infection and Long-Lasting Viral Suppression
Clinical Infectious Diseases, 2002
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections
Hepatology, 2002
Pharmacokinetic Interactions of Nevirapine and Methadone and Guidelines for Use of Nevirapine to Treat Injection Drug Users
Clinical Infectious Diseases, 2001
Substitution of a Nonnucleoside Reverse Transcriptase Inhibitor for a Protease Inhibitor in the Treatment of Patients with Undetectable Plasma Human Immunodeficiency Virus Type 1 RNA
Clinical Infectious Diseases, 2000
Antiretrovirals
Mayo Clinic Proceedings, 1999
Maintenance Antiretroviral Therapies in HIV-Infected Subjects with Undetectable Plasma HIV RNA after Triple-Drug Therapy
New England Journal of Medicine, 1998
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
New England Journal of Medicine, 1998
National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).
Circulation, 1994